BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1896110)

  • 1. Cyclophosphamide pulse therapy in relapsing nephrotic syndrome.
    Wardle EN
    Nephron; 1991; 58(3):377. PubMed ID: 1896110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Childhood Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome in Saudi Children.
    Alharthi AA
    Clin Pediatr (Phila); 2017 Feb; 56(2):177-183. PubMed ID: 27130200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R; de Jong M; Monnens L
    Ned Tijdschr Geneeskd; 1992 May; 136(18):876-80. PubMed ID: 1589052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide pulse therapy in frequently relapsing nephrotic syndrome.
    Gandhi R; Thomas C
    Nephron; 1990; 55(4):444. PubMed ID: 2392204
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
    McCrory WW; Shibuya M; Lu WH; Lewy JE
    J Pediatr; 1973 Apr; 82(4):614-8. PubMed ID: 4698338
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclophosphamide in the treatment of childhood nephrotic syndrome.
    Wiggelinkhuizen J; McDonald R; Kaschula RO
    S Afr Med J; 1972 Sep; 46(39):1417-23. PubMed ID: 4642675
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.
    Barratt TM; Cameron JS; Chantler C; Ogg CS; Soothill JF
    Arch Dis Child; 1973 Apr; 48(4):286-90. PubMed ID: 4574639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of the nephrotic syndrome in childhood with emphasis on the role of cyclophosphamide.
    Kelsch RC; Oliver WJ
    Mich Med; 1972 Dec; 71(35):999-1003. PubMed ID: 4636891
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinicopathological study of nephrotic syndrome and role of immunosuppressive therapy.
    Prasad R; Dayal RS; Srivastava VK; Bhatnagar AK; Jain S; Kapur S
    Indian Pediatr; 1980 Dec; 17(12):923-9. PubMed ID: 7251119
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide therapy in the management of nephrotic syndrome.
    Srivastava RN; Mayekar G; Anand R; Choudhry VP; Ghai OP
    Indian Pediatr; 1974 Dec; 11(12):767-74. PubMed ID: 4448539
    [No Abstract]   [Full Text] [Related]  

  • 14. Observations on the "minimal change" lesion: adult onset patients and results of cyclophosphamide treatment in children.
    Cameron JS; Ogg CS; White RH
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():211-6. PubMed ID: 4536423
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of cyclophosphamide on children with steroid resistant nephrotic syndrome and its side effect upon the gonadal tissue.
    Wila W; Alatas H; Tambunan T; Khow LP; Ramelan W
    Paediatr Indones; 1976; 16(7-8):291-8. PubMed ID: 1004929
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.
    Drummond KN; Hillman DA; Marchessault JH; Feldman W
    Can Med Assoc J; 1968 Mar; 98(11):524-31. PubMed ID: 5643296
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of cyclophosphamide treatment of primary nephrotic syndrome in children].
    Starkiewiczowa J; Fydryk J; Lupa B
    Pediatr Pol; 1975 Jan; 50(1):31-6. PubMed ID: 1110844
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute lymphoblastic leukaemia after treatment of nephrotic syndrome with immunosuppressive drugs.
    Kuis W; de Kraker J; Kuijten RH; Donckerwolcke RA; Voƻte PA
    Helv Paediatr Acta; 1976 Jun; 31(1):91-5. PubMed ID: 1065623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.
    Vester U; Kranz B; Zimmermann S; Hoyer PF
    Pediatr Nephrol; 2003 Jul; 18(7):661-4. PubMed ID: 12750975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclophosphamide therapy of nephrotic syndrome in childhood].
    Krepler P; Rosenkranz A; Obiditsch-Mayer I; Stockinger L; Schatz H; Fritzsche H
    Arch Kinderheilkd; 1970; 181(3):268-82. PubMed ID: 4922851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.